{"id":"https://openalex.org/W7083463969","doi":"https://doi.org/10.35629/4494-1005444450","title":"Method Development and Validation for the Simultaneous Estimation of Ceftriaxone and Tazobactam in Bulk and Pharmaceutical Dosage Forms by Rp-Hplc","display_name":"Method Development and Validation for the Simultaneous Estimation of Ceftriaxone and Tazobactam in Bulk and Pharmaceutical Dosage Forms by Rp-Hplc","publication_year":2025,"publication_date":"2025-05-01","ids":{"openalex":"https://openalex.org/W7083463969","doi":"https://doi.org/10.35629/4494-1005444450"},"language":"en","primary_location":{"id":"doi:10.35629/4494-1005444450","doi":"https://doi.org/10.35629/4494-1005444450","is_oa":true,"landing_page_url":"https://doi.org/10.35629/4494-1005444450","pdf_url":"https://doi.org/10.35629/4494-1005444450","source":{"id":"https://openalex.org/S5407000610","display_name":"International Journal of Pharmaceutical Research and Applications","issn_l":"2456-4494","issn":["2456-4494"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutical Research and Applications","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.35629/4494-1005444450","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5104142871","display_name":"PV Madhavi Latha","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dr. P. V. Madhavi Latha","raw_affiliation_strings":["- Viswanadha Institute Of Pharmaceutical Sciences Visakhapatnam , Andhra Pradesh , India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"- Viswanadha Institute Of Pharmaceutical Sciences Visakhapatnam , Andhra Pradesh , India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069484260","display_name":"Nagamani Bolla","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dr. Nagamani Bolla","raw_affiliation_strings":["- Viswanadha Institute Of Pharmaceutical Sciences Visakhapatnam , Andhra Pradesh , India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"- Viswanadha Institute Of Pharmaceutical Sciences Visakhapatnam , Andhra Pradesh , India","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ms. K. Suvarna Ms. K. Suvarna","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ms. K. Suvarna Ms. K. Suvarna","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5076888976","display_name":"P. Uma Devi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dr. P. Uma Devi Dr. P. Uma Devi","raw_affiliation_strings":["- Viswanadha Institute Of Pharmaceutical Sciences Visakhapatnam , Andhra Pradesh , India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"- Viswanadha Institute Of Pharmaceutical Sciences Visakhapatnam , Andhra Pradesh , India","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.31132462,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"5","first_page":"444","last_page":"450"},"is_retracted":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ceftriaxone","display_name":"ceftriaxone","score":0.9950000047683716},{"id":"https://openalex.org/keywords/tazobactam","display_name":"tazobactam","score":1.0},{"id":"https://openalex.org/keywords/joint-estimation","display_name":"simultaneous estimation","score":0.9100000262260437},{"id":"https://openalex.org/keywords/dosage-forms","display_name":"pharmaceutical dosage forms","score":0.7730000019073486},{"id":"https://openalex.org/keywords/bulk-drug-analysis","display_name":"bulk drug analysis","score":0.6169999837875366},{"id":"https://openalex.org/keywords/method-validation","display_name":"method validation","score":0.6029999852180481},{"id":"https://openalex.org/keywords/quality-control","display_name":"quality control","score":0.7089999914169312},{"id":"https://openalex.org/keywords/cephalosporins","display_name":"cephalosporins","score":0.7239999771118164},{"id":"https://openalex.org/keywords/beta-lactamase-inhibitors","display_name":"beta-lactamase inhibitors","score":0.6660000085830688}],"concepts":[{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.8090000152587891},{"id":"https://openalex.org/C2778266534","wikidata":"https://www.wikidata.org/wiki/Q423376","display_name":"Tazobactam","level":5,"score":0.7135999798774719},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.683899998664856},{"id":"https://openalex.org/C2776520383","wikidata":"https://www.wikidata.org/wiki/Q421713","display_name":"Ceftriaxone","level":3,"score":0.6585999727249146},{"id":"https://openalex.org/C3020018676","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Retention time","level":2,"score":0.5113999843597412},{"id":"https://openalex.org/C204320433","wikidata":"https://www.wikidata.org/wiki/Q7268772","display_name":"Quality by Design","level":3,"score":0.4530999958515167},{"id":"https://openalex.org/C73826308","wikidata":"https://www.wikidata.org/wiki/Q684907","display_name":"Elution","level":2,"score":0.44200000166893005},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3898000121116638},{"id":"https://openalex.org/C106186310","wikidata":"https://www.wikidata.org/wiki/Q1437823","display_name":"Pharmaceutical formulation","level":2,"score":0.3571999967098236},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.35370001196861267},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.32829999923706055},{"id":"https://openalex.org/C45904493","wikidata":"https://www.wikidata.org/wiki/Q912807","display_name":"Active ingredient","level":2,"score":0.3206999897956848},{"id":"https://openalex.org/C2779607525","wikidata":"https://www.wikidata.org/wiki/Q14982","display_name":"Methanol","level":2,"score":0.31450000405311584},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.31450000405311584},{"id":"https://openalex.org/C45188465","wikidata":"https://www.wikidata.org/wiki/Q645497","display_name":"Reversed-phase chromatography","level":3,"score":0.3077000081539154},{"id":"https://openalex.org/C3017686574","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"Gradient elution","level":3,"score":0.27730000019073486}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.35629/4494-1005444450","doi":"https://doi.org/10.35629/4494-1005444450","is_oa":true,"landing_page_url":"https://doi.org/10.35629/4494-1005444450","pdf_url":"https://doi.org/10.35629/4494-1005444450","source":{"id":"https://openalex.org/S5407000610","display_name":"International Journal of Pharmaceutical Research and Applications","issn_l":"2456-4494","issn":["2456-4494"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutical Research and Applications","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.35629/4494-1005444450","doi":"https://doi.org/10.35629/4494-1005444450","is_oa":true,"landing_page_url":"https://doi.org/10.35629/4494-1005444450","pdf_url":"https://doi.org/10.35629/4494-1005444450","source":{"id":"https://openalex.org/S5407000610","display_name":"International Journal of Pharmaceutical Research and Applications","issn_l":"2456-4494","issn":["2456-4494"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutical Research and Applications","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.4000000059604645,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.5856009721755981,"display_name":"Industry, innovation and infrastructure","id":"https://metadata.un.org/sdg/9"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7083463969.pdf","grobid_xml":"https://content.openalex.org/works/W7083463969.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"A":[0],"simple,":[1],"accurate":[2],"and":[3,13,21,25,52,85,93,108,121,133,148],"precise":[4],"High":[5],"Performance":[6],"Liquid":[7],"Chromatographic":[8],"(HPLC)":[9],"method":[10,30,99,144],"was":[11,31,75,100,111,146],"developed":[12,32,98,145],"validated":[14,101],"for":[15,114],"the":[16,55,115,124,131,143],"simultaneous":[17,116],"estimation":[18,118],"of":[19,67,70,83,119],"Ceftriaxone":[20,84,120],"Tazobactam":[22,86,122],"in":[23,54,59,123,154,159],"bulk":[24],"Pharmaceutical":[26,125],"dosage":[27,126],"forms.":[28],"The":[29,73,97],"using":[33],"Waters":[34],"HPLC":[35],"system":[36],"with":[37,102],"Inertsil":[38],"\u2013":[39],"C18,":[40],"ODS":[41],"column":[42],"(250":[43],"x":[44],"4.6":[45],"mm,":[46],"5\u00b5).":[47],"Mobile":[48],"phase":[49],"containing":[50],"Methanol":[51],"buffer":[53],"ratio":[56],"80:20":[57],"v/v":[58],"isocratic":[60],"elution":[61],"mode":[62],"at":[63,78],"a":[64],"flow":[65],"rate":[66],"1.0ml/min":[68],"(load":[69],"20\u00b5l)":[71],".":[72],"detection":[74],"carried":[76],"out":[77],"254":[79],"nm.":[80],"Retention":[81],"time":[82,135],"were":[87,136],"found":[88],"to":[89,104],"be":[90,152],"3.049":[91],"min":[92,95],"4.317":[94],"respectively.":[96],"respect":[103],"linearity,":[105],"robustness,":[106],"precision":[107],"accuracy.":[109],"It":[110],"successfully":[112],"applied":[113],"quantitative":[117],"form.":[127],"Results":[128],"show":[129],"that":[130,142,150],"retention":[132],"run":[134],"decreased,":[137],"so":[138],"it":[139],"is":[140],"evident":[141],"simple":[147],"economical":[149],"can":[151],"adopted":[153],"regular":[155],"Quality":[156],"control":[157],"test":[158],"Industries":[160]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}